Social media

From wearables to ePROs, trials are data-rich and decentralised. CRAs must evolve. ICON’s Helen Yeardley explores this evolution in Applied Clinical Trials. https://ow.ly/TNaS50XB6Sc

Long-term follow-up for vaccines may seem to be a distant concern when clinical trials are just beginning, but it can be critical to have a plan for follow-up at the outset. Learn considerations for follow-up design, s...

Collecting data through clinical trial tokenisation enables a longitudinal view of patient health, with insights from before and after a clinical trial. This can help to identify factors that may influence the effectiv...

Only 1 week to go. Don’t miss out on your opportunity to hear from ICON’s clinical trial regulatory experts, Jo Hulbert and Jo Sprague on the changes in ICH GCP E6(R3) and the how to assess the impact, risk and requireme...

Only 1 week to go. Don’t miss out on your opportunity to hear from ICON’s clinical trial regulatory experts, Joanne Hulbert, MBA & Joanna Sprague on the changes in ICH GCP E6(R3) and the how to assess the impact, risk ...

Tired of stitching together fragmented market data? Metys®, from Symphony Health, an ICON plc company, is the only fully integrated platform that consolidates over 150 metrics and dimensions – giving you a complete, rea...

Tired of stitching together fragmented market data? Metys®, from Symphony Health, an ICON plc company, is the only fully integrated platform that consolidates over 150 metrics and dimensions – giving you a complete, rea...

Quality and compliance shape every part of clinical research. For anyone considering a career in this field, understanding these foundations can make the path ahead clearer and more rewarding. Our latest blog explain...

Quality and compliance shape every part of clinical research. For anyone considering a career in this field, understanding these foundations can make the path ahead clearer and more rewarding. Our latest blog explain...

We’re excited to share groundbreaking research from Sanofi and Symphony Health, an ICON plc company, published in JMIR! Using Symphony Health’s real-world claims data, the study shows that Dario’s digital diabetes solut...

We’re proud to share that Sanofi and Symphony Health, an ICON plc company, have published a peer-reviewed study in JMIR leveraging Symphony Health’s real-world claims data to evaluate the impact of Dario’s digital diabet...

Site activation can take months. Learn how ICON is helping sponsors cut timelines in half with AI-powered tools and site-centric planning. Read the whitepaper: https://ow.ly/f5EO50XB6ZL